Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. [electronic resource]
Producer: 20100615Description: 8-14 p. digitalISSN:- 1555-8576
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Breast Neoplasms, Male -- drug therapy
- Carcinoma -- drug therapy
- Curcumin -- administration & dosage
- Diarrhea -- chemically induced
- Docetaxel
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Feasibility Studies
- Female
- Follow-Up Studies
- Humans
- Leukopenia -- chemically induced
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Metastasis -- drug therapy
- Neutropenia -- chemically induced
- Taxoids -- administration & dosage
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.